Stephane Lolignier
Gower Street
London, ENG, United Kingdom
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
LPS2336, a New TREK-1 Channel Activator Identified by High Throughput Screening.
Journal: Biomolecules
Published: March 31, 2025
The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 19, 2024
Antihyperalgesic properties of gut microbiota: Parabacteroides distasonis as a new probiotic strategy to alleviate chronic abdominal pain.
Journal: Pain
Published: January 11, 2023
Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity.
Journal: Molecular neurobiology
Published: December 09, 2020
TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.
Journal: British journal of pharmacology
Published: October 28, 2019
Replacement of current opioid drugs focusing on MOR-related strategies.
Journal: Pharmacology & therapeutics
Published: June 04, 2019
Inhibition of somatosensory mechanotransduction by annexin A6.
Journal: Science signaling
Published: June 21, 2018
Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene-targeted mice.
Journal: The EMBO journal
Published: April 05, 2017
Development of the First Two-Pore Domain Potassium Channel TWIK-Related K+ Channel 1-Selective Agonist Possessing in Vivo Antinociceptive Activity.
Journal: Journal of medicinal chemistry
Published: January 05, 2017
New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical Perspectives.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: July 22, 2016
Last Updated: 09/26/2026